← Leaderboards
Murat Bastepe
Massachusetts General Hospital
$9,215,842
Attributed
$9,215,842
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,215,842 · 5
By mechanism
R01$8,376,596 · 3
R21$449,636 · 1
K01$389,610 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Harald W. Jueppner$19,159,604
- Marie Demay$19,218,520
- Thomas J Gardella$10,202,128
- Henry M Kronenberg$26,229,120
- Arno W Tilles$4,868,169
Others in their field
Top investigators on “Signal Transduction”
- Peter B. Gilbert · Fred Hutchinson Cancer Center$148,539,615
- David Heimbrook · Leidos Biomedical Research, Inc.$82,049,940
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$70,290,471
- Garret A Fitzgerald · University Of Pennsylvania$66,142,222
- Michael Barry Kastan · Duke University$64,512,357
- Randall J Bateman · Washington University$62,939,456
Research focus
Signal TransductionCellsMediatingPhenotypeHuman DiseaseHormonesRegulationPathogenesisKidneyMouse ModelResponseCell LineSignal PathwayAblationPseudohypoparathyroidismKnockout MiceGtp-Binding ProteinsInorganic PhosphateSerumMutationGenerationsInheritedMetabolismPlay
Grant awards (27)
Control of allelic Gsα expression for regulating hormone signaling$553,545
R01 · FY2025 · DK · contact PI
siRNA-based treatment approach to enhance Gs alpha-mediated hormone signaling$449,636
R21 · FY2025 · HD · contact PI
Control of allelic Gsα expression for regulating hormone signaling$553,545
R01 · FY2024 · DK · contact PI
Skeletal FGF23 production mediated by GPCR/Gq/PKC signaling$392,025
R01 · FY2024 · DK · contact PI
Skeletal FGF23 production mediated by GPCR/Gq/PKC signaling$408,359
R01 · FY2023 · DK · contact PI
Skeletal FGF23 production mediated by GPCR/Gq/PKC signaling$408,359
R01 · FY2022 · DK · contact PI
Skeletal FGF23 production mediated by GPCR/Gq/PKC signaling$408,359
R01 · FY2021 · DK · contact PI
Skeletal FGF23 production mediated by GPCR/Gq/PKC signaling$389,863
R01 · FY2021 · DK · contact PI
XLas Relative to Gsa in Bone and Mineral Ion Metabolism$418,103
R01 · FY2020 · DK · contact PI
Skeletal FGF23 production mediated by GPCR/Gq/PKC signaling$408,359
R01 · FY2020 · DK · contact PI
XLas Relative to Gsa in Bone and Mineral Ion Metabolism$423,154
R01 · FY2019 · DK · contact PI
XLas Relative to Gsa in Bone and Mineral Ion Metabolism$424,442
R01 · FY2018 · DK · contact PI
XLas Relative to Gsa in Bone and Mineral Ion Metabolism$368,125
R01 · FY2018 · DK · contact PI
XLas Relative to Gsa in Bone and Mineral Ion Metabolism$424,422
R01 · FY2017 · DK · contact PI
XLas Relative to Gsa in Bone and Mineral Ion Metabolism$374,601
R01 · FY2015 · DK · contact PI
XLas Relative to Gsa in Bone and Mineral Ion Metabolism$373,502
R01 · FY2014 · DK · contact PI
XLas Relative to Gsa in Bone and Mineral Ion Metabolism$360,430
R01 · FY2013 · DK · contact PI
XLas Relative to Gsa in Bone and Mineral Ion Metabolism$373,677
R01 · FY2012 · DK · contact PI
Role of XLalphas as a novel alpha-subunit of Gs in hormone signaling$314,102
R01 · FY2010 · DK · contact PI
Role of XLalphas as a novel alpha-subunit of Gs in hormone signaling$39,564
R01 · FY2010 · DK · contact PI
Role of XLalphas as a novel alpha-subunit of Gs in hormone signaling$317,275
R01 · FY2009 · DK · contact PI
Role of XLalphas as a novel alpha-subunit of Gs in hormone signaling$1,760
R01 · FY2009 · DK · contact PI
Role of XLalphas as a novel alpha-subunit of Gs in hormone signaling$317,275
R01 · FY2008 · DK · contact PI
Role of XLalphas as a novel alpha-subunit of Gs in hormone signaling$323,750
R01 · FY2007 · DK · contact PI
Characterization of the "Gs-like" activity of Xlas$129,870
K01 · FY2005 · DK
Characterization of the "Gs-like" activity of Xlas$129,870
K01 · FY2004 · DK
Characterization of the "Gs-like" activity of XLalphas$129,870
K01 · FY2003 · DK